
Medical Oncology, Hematology

Stephen L. Richey, M.D., MPH, FACP, is board certified in hematology, internal medicine, and medical oncology. Dr. Richey has expertise in the treatment of melanoma, genitourinary (kidney, bladder, prostate, testicular cancers), breast, lung, head and neck, and gastrointestinal cancers. He also has expertise is lymphoma and leukemia. Dr. Richey is a member of the US Oncology Network phase 1 drug development program. He has held positions on the US Oncology Genitourinary Cancer Research Committee, the US Oncology Research Executive Committee, and the Texas Oncology Board of Directors. He is active in clinical research and is the principal investigator of clinical trials or various malignancies. He has expertise in immunotherapy, targeted therapy, and chemotherapy approaches to cancer treatment. Dr. Richey is actively involved in the most current phase I through phase III clinical trials through US Oncology Research Network.
Fellowship in Hematology and Oncology
The University of Texas MD Anderson Cancer Center, Houston, Texas
Internship and Residency in Internal Medicine
The University of Texas Health Science Center, Houston, Texas
Medical Doctorate
Louisiana State University Health Science Center School of Medicine, New Orleans, Louisiana
Master of Science in Public Health
Louisiana State University Health Science Center School of Public Health, New Orleans, Louisiana
Bachelor of Science in Microbiology
Louisiana State University A&M, Baton Rouge, Louisiana
Stephen L. Richey, M.D., MPH, FACP, is board certified in hematology, internal medicine, and medical oncology. Dr. Richey has expertise in the treatment of melanoma, genitourinary (kidney, bladder, prostate, testicular cancers), breast, lung, head and neck, and gastrointestinal cancers. He also has expertise is lymphoma and leukemia. Dr. Richey is a member of the US Oncology Network phase 1 drug development program. He has held positions on the US Oncology Genitourinary Cancer Research Committee, the US Oncology Research Executive Committee, and the Texas Oncology Board of Directors. He is active in clinical research and is the principal investigator of clinical trials or various malignancies. He has expertise in immunotherapy, targeted therapy, and chemotherapy approaches to cancer treatment. Dr. Richey is actively involved in the most current phase I through phase III clinical trials through US Oncology Research Network.
Fellowship in Hematology and Oncology
The University of Texas MD Anderson Cancer Center, Houston, Texas
Internship and Residency in Internal Medicine
The University of Texas Health Science Center, Houston, Texas
Medical Doctorate
Louisiana State University Health Science Center School of Medicine, New Orleans, Louisiana
Master of Science in Public Health
Louisiana State University Health Science Center School of Public Health, New Orleans, Louisiana
Bachelor of Science in Microbiology
Louisiana State University A&M, Baton Rouge, Louisiana